103 related articles for article (PubMed ID: 4309849)
1. Antiviral activity of 9-beta-D-arabinofuranosyladenine. V. Activity against intracerebral Vaccinia virus infections in mice.
Dixon GJ; Sidwell RW; Miller FA; Sloan BJ
Antimicrob Agents Chemother (Bethesda); 1968; 8():172-9. PubMed ID: 4309849
[No Abstract] [Full Text] [Related]
2. The N6-(dimethylamino)methylene derivative of 9-beta-D-arabinofuranosyladenine as an antiviral agent.
Hanessian S
J Med Chem; 1973 Mar; 16(3):290-2. PubMed ID: 4354694
[No Abstract] [Full Text] [Related]
3. Antiviral activity of 0-beta-D-arabinofuranosyladenine. IV. Activity against intracerebral herpes simplex virus infections in mice.
Sloan BJ; Miller FA; Ehrlich J; McLean IW; Machamer HE
Antimicrob Agents Chemother (Bethesda); 1968; 8():161-71. PubMed ID: 4309848
[No Abstract] [Full Text] [Related]
4. Treatment of poxvirus infections in rabbits with 9-beta-D-arabinofuranosyladenine.
Klein RJ; Friedman-Kien AE; Brady E
Antimicrob Agents Chemother; 1974 Apr; 5(4):409-12. PubMed ID: 15825397
[TBL] [Abstract][Full Text] [Related]
5. Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections.
De Clercq E
Clin Microbiol Rev; 2001 Apr; 14(2):382-97. PubMed ID: 11292644
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiviral activity of certain 5'-monophosphates of 9-D-arabinofuranosyladenine and 9-D-arabinofuranosylhypoxanthine.
Revankar GR; Huffman JH; Allen LB; Sidwell RW; Robins RK; Tolman RL
J Med Chem; 1975 Jul; 18(7):721-6. PubMed ID: 1171242
[TBL] [Abstract][Full Text] [Related]
7. Nigericin is a potent inhibitor of the early stage of vaccinia virus replication.
Myskiw C; Piper J; Huzarewich R; Booth TF; Cao J; He R
Antiviral Res; 2010 Dec; 88(3):304-10. PubMed ID: 20951746
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of vaccinia virus by the antibiotic rifampicin.
Heller E; Argaman M; Levy H; Goldblum N
Nature; 1969 Apr; 222(5190):273-4. PubMed ID: 4305117
[No Abstract] [Full Text] [Related]
9. Antiviral activity of 9-beta-D-arabinofuranosyladenine. II. Activity against Herpes simplex keratitis in hamsters.
Sidwell RW; Dixon GJ; Schabel FM; Kaump DH
Antimicrob Agents Chemother (Bethesda); 1968; 8():148-54. PubMed ID: 5735359
[No Abstract] [Full Text] [Related]
10. [Ineffectiveness of rifomycin in the treatment of vaccinia pneumonia in the mouse].
Gut JP; Kirn A
Pathol Biol (Paris); 1972 Apr; 20(7):349-51. PubMed ID: 4339206
[No Abstract] [Full Text] [Related]
11. Antiviral activity of 9-beta-D-arabinofuranosyladenine. 3. Reduction in evidence of encephalitis in treated herpes Simplex-infected hamsters.
Schardein JL; Sidwel RW
Antimicrob Agents Chemother (Bethesda); 1968; 8():155-60. PubMed ID: 4309847
[No Abstract] [Full Text] [Related]
12. Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
De Clercq E; Andrei G; Balzarini J; Leyssen P; Naesens L; Neyts J; Pannecouque C; Snoeck R; Ying C; Hocková D; Holý A
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):331-41. PubMed ID: 16247948
[TBL] [Abstract][Full Text] [Related]
13. The antiviral activity of 9-beta-D-arabinofuranosyladenine (ARA-A).
Schabel FM
Chemotherapia (Basel); 1968; 13(6):321-38. PubMed ID: 4305653
[No Abstract] [Full Text] [Related]
14. In vitro and in vivo evaluation of isatin-beta-thiosemicarbazone and marboran against vaccinia and cowpox virus infections.
Quenelle DC; Keith KA; Kern ER
Antiviral Res; 2006 Aug; 71(1):24-30. PubMed ID: 16621041
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of delayed brincidofovir treatment against a lethal rabbitpox virus challenge in New Zealand White rabbits.
Grossi IM; Foster SA; Gainey MR; Krile RT; Dunn JA; Brundage T; Khouri JM
Antiviral Res; 2017 Jul; 143():278-286. PubMed ID: 28392420
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study on the effect of fusidin on vaccine poxvirus].
Goncharskaia IIa; Navashin SM
Antibiotiki; 1973 Aug; 18(8):710-3. PubMed ID: 4359863
[No Abstract] [Full Text] [Related]
17. Anti-DNA virus activity of the 5'-nucleotide and 3',5'-cyclic nucleotide of 9-beta-D-arabinofuranosyladenine.
Sidwell RW; Allen LB; Huffman JH; Khwaja TA; Tolman RL; Robins RK
Chemotherapy; 1973; 19(6):325-40. PubMed ID: 4367867
[No Abstract] [Full Text] [Related]
18. Effect of oral treatment with hexadecyloxypropyl-[(S)-9-(3-hydroxy-2- phosphonylmethoxypropyl)adenine] [(S)-HPMPA] or octadecyloxyethyl-(S)-HPMPA on cowpox or vaccinia virus infections in mice.
Quenelle DC; Collins DJ; Herrod BP; Keith KA; Trahan J; Beadle JR; Hostetler KY; Kern ER
Antimicrob Agents Chemother; 2007 Nov; 51(11):3940-7. PubMed ID: 17846137
[TBL] [Abstract][Full Text] [Related]
19. Antiviral effect of trimeric 2',5'-oligoadenylic acid and some of its analogues.
Tkachuk ZYu ; Semernikova LI; Tkachuk VV; Reshot'ko LM; Tkachuk LV; Eremenko T; Matsuka GK; Mikhailopulo IA
New Microbiol; 1998 Apr; 21(2):141-6. PubMed ID: 9579338
[TBL] [Abstract][Full Text] [Related]
20. Parapoxviruses are strongly inhibited in vitro by cidofovir.
Nettleton PF; Gilray JA; Reid HW; Mercer AA
Antiviral Res; 2000 Dec; 48(3):205-8. PubMed ID: 11164507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
